2014 AUA Clinical Guideline on Overactive Bladder for Urologists: A Panel Discussion
Course InformationAccess Materials To ensure consistent, high quality, evidence-based treatment of patients with OAB, the AUA released the Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline (2012). The guideline focuses on the diagnosis and treatment of OAB and contains useful tools for providers such as a treatment algorithm. However, the field of OAB has rapidly evolved and there have been significant advances since the development of this guideline. As such, the AUA released it’s first-ever guideline amendment to the OAB Clinical Guideline in May 2014 Annual Meeting. With the release of a new clinical guideline amendment, physicians need up-to-date education focused on the diagnosis and treatment of OAB.
This activity provides an opportunity for urologists to maintain currency and timeliness regarding the best therapies for treatment available, as stated in the AUA Guideline. This activity not only presents new evidence recommendations for treatment, but panelists discuss common clinical scenarios and apply the elements of the AUA guideline to clinical practice.
After attending this activity, participants should be able to:
- Demonstrate an enhanced understanding of the condition of OAB utilizing the appropriate clinical factors for diagnosis and treatment.
- Analyze the evidence on the diagnosis and treatment of Overactive Bladder as outlined in the AUA guidelines and subsequent publications and engage the appropriate pathway for treatment.
- Improve diagnostic and therapeutic decision-making processes by illustrating the application of these guidelines in primary care practice.
- Evaluate treatment and monitor for adverse effects, treating patients and employing proper duration according to the AUA guideline.
- Practicing Urologists
We would like to sincerely thank Astellas Scientific and Medical Affairs for providing an educational grant which combined with AUA funding to support the promotion and distribution of the panel discussion video for Overactive Bladder. Consistent with the AUA strict conflict of interest policy, Astellas Scientific and Medical Affairs had no access to the AUA guidelines panels, played no part in the research or development of AUA guidelines and did not review them prior to publication. The co-support offered by Astellas Scientific and Medical Affairs, and gratefully accepted by the AUA, sincerely was in the best interest of the educational mission of the guidelines, to help you and your practice.